Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JUVEDERM VOLUMA + lidocaine is a sterile, injectable gel composed of cross-linked hyaluronic acid (20 mg/ml) and lidocaine (0.3%). It is designed to restore lost volume and enhance facial contours in the cheeks, chin, cheekbones, and jawline of adults. Hyaluronic acid works by retaining moisture in the skin and providing structural support through its viscoelastic and volumizing properties. Lidocaine is included to reduce pain during the injection procedure. This product employs advanced cross-linking technology (such as HYLACROSS or Vycross) to create a cohesive, homogenous gel suitable for deep dermal, subcutaneous, or upper-periosteal injection, with effects lasting up to 18 months. The filler integrates into tissue and stimulates collagen and elastin, improving elasticity and structure[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JUVEDERM VOLUMA + lidocaine.